机译:HER3过表达是肝外胆管癌的预后指标
Department of Pathology Asan Medical Center University of Ulsan College of Medicine 388-1 Pungnap-dong Songpa-gu Seoul 138-736 Korea;
Applied Molecular Pathology Laboratory and Tissue Array Research Program Laboratory of Pathology National Cancer Institute National Institutes of Health Bethesda MD USA;
Applied Molecular Pathology Laboratory and Tissue Array Research Program Laboratory of Pathology National Cancer Institute National Institutes of Health Bethesda MD USA;
Department of Pathology Asan Medical Center University of Ulsan College of Medicine 388-1 Pungnap-dong Songpa-gu Seoul 138-736 Korea;
Department of Pathology Asan Medical Center University of Ulsan College of Medicine 388-1 Pungnap-dong Songpa-gu Seoul 138-736 Korea;
Extrahepatic; Bile duct; Cholangiocarcinoma; HER2; HER3; Immunohistochemistry; Prognosis;
机译:HER3过表达是肝外胆管癌的预后指标
机译:发色原位杂交和免疫组织化学检测人肝外胆管癌中HER-2 / neu的基因扩增和蛋白过表达:其对淋巴结阳性患者的预后意义。
机译:生色原位杂交和免疫组化检测人肝外胆管癌中HER-2 / neu的基因扩增和蛋白过表达:其在淋巴结阳性患者中的预后意义
机译:通过指标准备水平对预后绩效指标的评级
机译:根据患者特征预测焦虑症诊所的治疗结果:预后指标评定表。
机译:肝内胆管癌中白细胞介素35的过表达是根治性切除后的预后指标
机译:在肝内胆管癌中白细胞介素-35的过度表达是治疗切除后的预后指示剂